Interferon α kinoid induces neutralizing anti-interferon α antibodies that decrease the expression of interferon-induced and B cell activation associated transcripts: analysis of extended follow-up data from the interferon α kinoid phase I/II study
Julie Ducreux(UCLouvain), Bernard Lauwerys(UCLouvain), François Spertini(University Hospital of Lausanne), Frédéric Houssiau(Cliniques Universitaires Saint-Luc), Marion Laborie(Neovacs (France)), Géraldine Grouard-Vogel(Neovacs (France)), F. Colaone(Neovacs (France)), Christian Jørgensen(Inserm), Pierre Vandepapelière(Neovacs (France)), Estibaliz Lazaro(Centre National de la Recherche Scientifique), Camille Roucairol(Neovacs (France)), Thérèse Croughs(Neovacs (France))
Cited by 84
Related Papers
EULAR recommendations for the management of systemic lupus erythematosus: 2023 update
|Annals of the Rheumatic Diseases|2023|913
Treat-to-target in systemic lupus erythematosus: recommendations from an international task force
|Annals of the Rheumatic Diseases|2014|726
Adipose Mesenchymal Stromal Cell-Based Therapy for Severe Osteoarthritis of the Knee: A Phase I Dose-Escalation Trial
|Stem Cells Translational Medicine|2016|493
Further characterization of clinical and laboratory features in VEXAS syndrome: large‐scale analysis of a multicentre case series of 116 French patients*
|British Journal of Dermatology|2021|414
A framework for remission in SLE: consensus findings from a large international task force on definitions of remission in SLE (DORIS)
|Annals of the Rheumatic Diseases|2016|355